141 related articles for article (PubMed ID: 20418785)
1. Vincristine and intestinal pseudo-obstruction in children: report of 5 cases, literature review, and suggested management.
Diezi M; Nydegger A; Di Paolo ER; Kuchler H; Beck-Popovic M
J Pediatr Hematol Oncol; 2010 May; 32(4):e126-30. PubMed ID: 20418785
[TBL] [Abstract][Full Text] [Related]
2. Vincristine-induced paralytic ileus during induction therapy of treatment protocols for acute lymphoblastic leukemia in adult patients.
Yasu T; Ohno N; Kawamata T; Kurokawa Y
Int J Clin Pharmacol Ther; 2016 Jun; 54(6):471-3. PubMed ID: 27087157
[TBL] [Abstract][Full Text] [Related]
3. A trial to assess the efficacy of glutamic acid in prevention of vincristine-induced neurotoxicity in pediatric malignancies: a pilot study.
Mokhtar GM; Shaaban SY; Elbarbary NS; Fayed WA
J Pediatr Hematol Oncol; 2010 Nov; 32(8):594-600. PubMed ID: 20921909
[TBL] [Abstract][Full Text] [Related]
4. Vincristine-induced unilateral ptosis in a child.
Gursel O; Sari E; Altun D; Atay AA; Akin R
Pediatr Neurol; 2009 Dec; 41(6):461-3. PubMed ID: 19931172
[TBL] [Abstract][Full Text] [Related]
5. Pyridoxine treatment of vincristine-induced cranial polyneuropathy in an adult patient with acute lymphocytic leukemia: Case report and review of the literature.
Ngamphaiboon N; Sweeney R; Wetzler M; Wang ES
Leuk Res; 2010 Aug; 34(8):e194-6. PubMed ID: 20167372
[No Abstract] [Full Text] [Related]
6. Severe vincristine toxicity in combination with itraconazole.
Gillies J; Hung KA; Fitzsimons E; Soutar R
Clin Lab Haematol; 1998 Apr; 20(2):123-4. PubMed ID: 9681224
[TBL] [Abstract][Full Text] [Related]
7. "Vincristine overdosage in paediatric patients".
Stones DK
Med Pediatr Oncol; 1998 Mar; 30(3):193. PubMed ID: 9434832
[No Abstract] [Full Text] [Related]
8. Severe life threatening neurotoxicity in a child with acute lymphoblastic leukemia receiving posaconazole and vincristine.
Jain S; Kapoor G
Pediatr Blood Cancer; 2010 May; 54(5):783. PubMed ID: 20205256
[No Abstract] [Full Text] [Related]
9. [Neurological complications of treatments with vincristine. Clinical study of 100 patients treated with vincristine].
Goldstein B; Lhuillier M
Ann Med Interne (Paris); 1974; 125(6-7):571-6. PubMed ID: 4374109
[No Abstract] [Full Text] [Related]
10. Chronic intestinal pseudo-obstruction. A report of 27 cases and review of the literature.
Schuffler MD; Rohrmann CA; Chaffee RG; Brand DL; Delaney JH; Young JH
Medicine (Baltimore); 1981 May; 60(3):173-96. PubMed ID: 6894476
[TBL] [Abstract][Full Text] [Related]
11. Regarding "Intrathecal vincristine: 3 fatal cases and a review of the literature".
Walter AW
J Pediatr Hematol Oncol; 2010 May; 32(4):336-7. PubMed ID: 20445422
[No Abstract] [Full Text] [Related]
12. Decrease in motor performance in children with cancer is independent of the cumulative dose of vincristine.
Hartman A; van den Bos C; Stijnen T; Pieters R
Cancer; 2006 Mar; 106(6):1395-401. PubMed ID: 16453332
[TBL] [Abstract][Full Text] [Related]
13. Severe neurotoxicities in a case of Charcot-Marie-Tooth disease type 2 caused by vincristine for acute lymphoblastic leukemia.
Nishikawa T; Kawakami K; Kumamoto T; Tonooka S; Abe A; Hayasaka K; Okamoto Y; Kawano Y
J Pediatr Hematol Oncol; 2008 Jul; 30(7):519-21. PubMed ID: 18797198
[TBL] [Abstract][Full Text] [Related]
14. [Paralytic ileus, convulsions and hyponatremia during vincristine treatment. Observations on a case in a young girl with acute lymphocytic leukemia].
Lorini R; Larizza D; Garibaldi E; Polito E
Minerva Pediatr; 1977 Sep; 29(28):1733-8. PubMed ID: 270010
[No Abstract] [Full Text] [Related]
15. Interactions between acute lymphoblastic leukemia and bone marrow stromal cells influence response to therapy.
Tesfai Y; Ford J; Carter KW; Firth MJ; O'Leary RA; Gottardo NG; Cole C; Kees UR
Leuk Res; 2012 Mar; 36(3):299-306. PubMed ID: 21889797
[TBL] [Abstract][Full Text] [Related]
16. Vincristine-induced vocal cord palsy: case report and review of the literature.
Latiff ZA; Kamal NA; Jahendran J; Alias H; Goh BS; Syed Zakaria SZ; Jamal R
J Pediatr Hematol Oncol; 2010 Jul; 32(5):407-10. PubMed ID: 20505534
[TBL] [Abstract][Full Text] [Related]
17. Obesity as a Potential Risk Factor for Vincristine-induced Peripheral Neuropathy.
Sajdyk TJ; Boyle FA; Foran KS; Tong Y; Pandya P; Smith EML; Ho RH; Wells E; Renbarger JL
J Pediatr Hematol Oncol; 2020 Oct; 42(7):e637-e640. PubMed ID: 31634238
[TBL] [Abstract][Full Text] [Related]
18. Treatment of Wilms tumor relapsing after initial treatment with vincristine and actinomycin D: a report from the National Wilms Tumor Study Group.
Green DM; Cotton CA; Malogolowkin M; Breslow NE; Perlman E; Miser J; Ritchey ML; Thomas PR; Grundy PE; D'Angio GJ; Beckwith JB; Shamberger RC; Haase GM; Donaldson M; Weetman R; Coppes MJ; Shearer P; Coccia P; Kletzel M; Macklis R; Tomlinson G; Huff V; Newbury R; Weeks D
Pediatr Blood Cancer; 2007 May; 48(5):493-9. PubMed ID: 16547940
[TBL] [Abstract][Full Text] [Related]
19. A case of severe toxicity during coadministration of vincristine and piperacillin: are drug transporters involved in vincristine hypersensitivity and drug-drug interactions?
Le Guellec C; Benz-de Bretagne I; Jonville-Bera AP; Tarfaoui N; Andres CR; Gendrot C; Jourdain A
J Pediatr Hematol Oncol; 2012 Nov; 34(8):e341-3. PubMed ID: 22627576
[TBL] [Abstract][Full Text] [Related]
20. Accidental intramuscular overdose administration of vincristine.
Patiroglu T; Unal E; Ozdemir MA; Karakukucu M; Mutlu FT
Drug Chem Toxicol; 2012 Apr; 35(2):232-4. PubMed ID: 21988109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
